Validation of the IMPROVE-DD risk assessment model for venous thromboembolism among hospitalized patients with COVID-19.
Spyropoulos AC, Cohen SL, Gianos E, Kohn N, Giannis D, Chatterjee S, Goldin M, Lesser M, Coppa K, Hirsch JS, McGinn T, Barish MA; COVID‐19 Consortium Group.
Spyropoulos AC, et al. Among authors: lesser m.
Res Pract Thromb Haemost. 2021 Feb 24;5(2):296-300. doi: 10.1002/rth2.12486. eCollection 2021 Feb.
Res Pract Thromb Haemost. 2021.
PMID: 33733028
Free PMC article.